Patent · US Active

MiRNA fingerprint in the diagnosis of prostate cancer

US9745630B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Hummingbird Diagnostics GmbH · DE

Inventors

Andreas Keller · Ettlingen, DE
Eckart Meese · Hütschenhausen, DE
Anne Borries · Heidelberg, DE
Markus Beier · Heidelberg, DE

Key dates

Filing date	Aug 11, 2015
Grant date	Aug 29, 2017
Priority date	—
Expiry date	Aug 11, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing prostate cancer based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.